Skip to content

Generate Biomedicines

US · GENB #2875 by market cap Listed 2026
9.54 -0.83 -8.00%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:32

About Generate Biomedicines

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Founded
2018
CEO
Mr. Michael Nally
Employees
312
Headquarters
Somerville, Massachusetts, United States of America
Fiscal year end
12-31
Website
generatebiomedicines.com

Company profile

Exchange
US
Symbol
GENB
Market-cap rank
#2875
Listing date
2026-02-27
Market cap
1.23B
Float cap
576.68M
Shares out
129.10M
Float shares
60.45M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:32:29 · For reference only, not investment advice and not tailored to your situation.

Generate Biomedicines discussion 0 comments

Add a comment